Our commitment to society

It’s about being ethical and innovative in everything we do, from research and development, to workplace, culture, and leadership.

That’s our commitment to society.

Forward, Sustainably!

Our approach

Our Sustainability strategy, initially defined in 2018, outlines our commitment in the transition towards a sustainable society. As a company, we firmly believe that we have to embrace new ways to move “Forward, Sustainably”.

In 2022, we decided to build on our key pillars and achievements and further evolve our sustainability approach to better respond to current opportunities and expectations.

Paul Stoffels

CEO Galapagos

We know that acting as a responsible and sustainable business is key to our success as we continue to focus on the needs of patients who trust and depend on us. That’s why we defined a 2028 call for action.

Our ambition by 2028

Years of life and quality of life

Add more years of life and quality of life for patients

Our ambition by 2028

Develop pivotal stage therapies

Develop pivotal stage therapies for patients, with patients and the healthcare community

Our ambition by 2028

Access across all continents

Provide patients access to our medicines across all continents

Our ambition by 2028

Diversity, Equity & Inclusion

Be a diverse, equitable and inclusive, and trusted organization

Our ambition by 2028

Be climate neutral

There’s no planet B. We are dedicated to achieving climate neutrality by 2028, as part of our unwavering commitment to environmental sustainability and carbon footprint reduction.

Goals and priorities

Our materiality assessment

Driven by our purpose to transform patient outcomes through life-changing science and innovation, we recognize that our activities have an impact that reaches well beyond our financial performance.

Read about our Materiality Assessment in more detail below.

Current and potential impact on society

To determine our key goals and priorities, we conducted a new Materiality Assessment in 2022, allowing us to identify the topics that are most relevant to our internal and external stakeholders. The analysis also enabled us to capture our current and potential impact on society and the world, and to effectively track areas in view of emerging challenges and opportunities.

Listening to our stakeholders

To enhance the value of the materiality assessment, we updated our methodology we applied for the 2018 materiality assessment and significantly increased the number of stakeholders participating in the assessment. Externally we engaged with representatives from patient organizations, patient experts, healthcare providers, supply chain partners, our collaboration partners, and investors. Internally, next to the members of our Executive Management and our Sustainability Steering Committee, all Galapagos employees were given the opportunity to provide input regarding the materiality of certain topics through a company-wide survey.

Internal and external stakeholders were invited to review a list of 35 potential material topics and to identify five topics they found most relevant, five topics they found less important for Galapagos and our core mission, and if any topic was missing.

Result: 4 pillars

The initial results further confirm the results from previous years with the top three pillars clustered around People, Planet, and Trust & Transparency with one main change: the desire to add a new pillar dedicated to Innovation for Patients.

We therefore adapted our focus areas and the four pillars as presented in the below materiality map.

Our pillars

4 material pillars

Patients

Our people

Planet

Trust & transparency

Integrating ESG in decision-making

Our sustainability governance

In 2022, supported by the members of our Executive Committee, we established a Sustainability Steering Committee, comprised of representatives from all departments within our organization. The Sustainability Committee ensures that environmental, social and governance considerations are fully integrated into the decision-making processes, including those related to the business strategy, key investments, and performance.